Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

0.2679
Delayed Data
As of Dec 02
 -0.0021 / -0.78%
Today’s Change
0.19
Today|||52-Week Range
1.20
-73.99%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close0.27
Today’s open0.26
Day’s range0.26 - 0.28
Volume143,389
Average volume (3 months)692,142
Market cap$30.8M
Dividend yield--
Data as of 3:55pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+11.54%
Earnings growth (this year)+19.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.69%
P/E ratioNM
Price/Sales8,984.64
Price/Book4.96

Competitors

 Today’s
change
Today’s
% change
VTGNVistaGen Therapeutic...+0.03+0.81%
CLBSCaladrius Bioscience...-0.18-4.81%
CANFCan Fite Biopharma L...+0.05+2.33%
HSGXHistogenics Corp-0.07-3.50%
Data as of 4:01pm ET, 12/02/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$10.4K
Annual profit (last year)-$20.9M
Net profit margin-200,671.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Richard J. Daly
Chief Financial Officer
Jonathan B. Lloyd Jones
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs